MFC Selected for National Project in Advanced Biotech and AI
Creatrip Team
a year ago
MFC, a company specializing in pharmaceutical ingredients, has been selected for a national project in the field of advanced biotechnology AI. The project will focus on developing a domestic platform for predicting and managing impurities in pharmaceuticals, currently reliant on foreign technology. This initiative aims to promote innovation and self-reliance while reducing the time and cost of drug development through AI. MFC plans to bolster its research center's capabilities in AI to develop high-value products and collaborate with leading institutions. This project is significant for Korea's biotech industry advancement.